Establishment and Application of Intelligent Reporting System for Adverse Drug Reactions in Hospitals

doi:10.19803/j.1672-8629.2020.02.06

Abstract

Abstract: Objective To streamline the workflow of reporting adverse drug reactions by the medical staff and improve the quality and timeliness of ADR reporting. Methods Based on the hospital information system and electronic medical record system, an ADR reporting system was developed on our own. This reporting system adopted Brower/Server architecture, Web-service, and EXT technology and related database Sql server 2010, and obtained data on electronic medical records through the Web-service technology. This adverse drug reaction system platform was incorporated into the hospital information system (HIS) and had a seamless connection with the Guangdong Province Adverse Drug Reaction Platform to achieve the integration of data collection, input, printing, export and reporting to provincial platforms. This system was able to monitor the whole process of ADR reporting in the hospital. Results In the four years after the ADR reporting system was applied, the hospital received a total of 2,864 reports of adverse drug reactions. This system simplified the ADR reporting process, made reporting less time-consuming, improved the quality of reporting, and ensured the accuracy of ADR reporting data. This system has also been adopted by other hospitals in the same district. Conclusion The establishment and application of the ADR reporting system can help reduce the workload of medical staff and improve the quality and efficiency of ADR reporting.

Key words: adverse drug reaction, monitoring, information system

CLC Number:

R994.11

ZHOU Hong, JIN Hongchang, QIN Jinfeng, ZHAO Feiyu, HE Renxian, XIE Lixia, TIAN Xiaodong. Establishment and Application of Intelligent Reporting System for Adverse Drug Reactions in Hospitals[J]. Chinese Journal of Pharmacovigilance, 2020, 17(2): 93-97.

References

[1] 胡文俊,蔡吉芬.我国药品不良反应报告与监测现状分析[J].中国药物警戒,2012,9(2):92-94.
[2] 国家食品药品监督管理局药品安全监管司,国家药品不良反应监测中心.药品不良反应报告和监测工作手册[G].北京:国家药品不良反应监测中心,2012.
[3] 耿魁魁,刘圣,沈爱宗.基于医院信息系统开展药物警戒的探索[J].中国药物警戒, 2012,19(2):77-80.
[4] 王玲. 基于医院信息系统开展药品不良反应监测研究[J].中国药物警戒, 2015,12(4);229-231.
[5] 余超,徐玉茗,李馨龄,等.我国医院信息系统与国家药品不良反应监测系统对接的需求调研[J].中国药物警戒,2016,13(3):154-158.
[6] Stang PE,Ryan PB,Racoonsin JA,et al.Advancing the science for active surveillance:rationale and design for the Observational Medical Outcomes Partnershop[J].Annals of internal Medicine,2010,153(9):600-606.
[7] 张晓雨,陈静,赵晨,等.真实世界理念下观察性与实验性临床研究协同应用[J]. 中国循证医学杂志,2018,18(4): 284-288.
[8] 李洪,魏来,郭晓蕙,等.真实世界研究伦理审查初探[J].中国循证医学杂志,2018,18(11): 1198-1202.
[9] 王雯,谭婧,于川,等.基于中国医院电子病历数据的药品安全性评价模式探索[J].中国药物警戒,2019,16(03):134-138.
[10] 孙鑫,谭婧,王雯,等.真实世界证据助推药械评价与监管决策[J].中国循证医学杂志,2019,05:521-526.
[11] 王琳琳,杨悦,王淑玲.美国FDA哨点系统的应用及启示[J].中国药物警戒,2019,16(2):81-87.
[12] 侯永芳,宋海波,刘红亮,等.基于中国医院药物警戒系统开展主动监测的实践与探讨[J]. 中国药物警戒,2019,16(4):212-214.
[13] 舒婷,陈文戈,侯永芳,等.基于HIS的哨点医院药物警戒系统的研究与应用[J].中国药房, 2017,28(25):3468-3471.
[14] 盛开,陈俊,熊宜军.药品不良反应监测与医院信息系统数据共享与对接管理的实现研究[J].江西中医药大学学报,2017, 29(5): 97-100.
[15] 徐玉茗,李馨龄,王玲,等.医院信息系统与国家药品不良反应监测系统对接的探索[J].中国医药导刊, 2017,19(3):317-318.
[16] 史涛,朱诗塔.医院药品不良反应计算机监测技术的发展概况[J].中国药房, 2010, 21(37):3456-3457.